[Skip to Content]
[Skip to Content Landing]
March 1953


Author Affiliations

New York (32)

AMA Arch Intern Med. 1953;91(3):414. doi:10.1001/archinte.1953.00240150133013

This article is only available in the PDF format. Download the PDF to view the article, as well as its associated figures and tables.


To the Editor::  —The review of the booklet on bacitracin which appears on page 424 of the September issue of the Archives of Internal Medicine has recently been brought to my attention. I should like to point out some fallacies in that review.The reviewer says that there are "many statements in this book which are hardly warranted on the basis of present-day knowledge," but he has not pointed out one such statement. Those that he uses as illustrations are inaccurate. Contrary to what the reviewer has stated, the book covers fully all of the studies on the nephrotoxic element in bacitracin reported up to the time of publication. Furthermore, nowhere in the book is the statement made that bacitracin is the treatment of choice in amebiasis.Contrary to what the reviewer has stated, (1) nephrotoxicity was of minor importance in the last 250 cases reported; (2) the purity of

First Page Preview View Large
First page PDF preview
First page PDF preview